U.S. Markets close in 1 hr 13 mins

BioDelivery Sciences International, Inc. (BDSI)

NASDAQ Capital Market - NASDAQ Capital Market Real Time Price. Currency in USD
Add to watchlist
3.158+0.058 (+1.871%)
As of 2:47PM EDT. Market open.
People also watch
FOLDBCRXSPPIACHNARRY
Full screen
Previous Close3.100
Open3.050
Bid3.150 x 2200
Ask3.200 x 4600
Day's Range3.050 - 3.275
52 Week Range1.500 - 3.600
Volume318,048
Avg. Volume550,065
Market Cap175.19M
Beta1.32
PE Ratio (TTM)-3,158.00
EPS (TTM)-0
Earnings DateNov 7, 2017 - Nov 13, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.50
Trade prices are not sourced from all markets
  • American City Business Journals28 minutes ago

    BDSI CEO to retire

    Dr. Mark Sirgo – who has served as president and CEO of Raleigh-based BioDelivery Sciences International (BDSI) since 2005 – will retire at the end of this year. “Furthermore, we benefit from the fact that Purdue is already familiar with marketing a buprenorphine-based product for pain (Butrans).

  • BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman
    PR Newswire7 hours ago

    BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman

    RALEIGH, N.C., Aug. 23, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) announced today that at the end of 2017, Dr. Mark A. Sirgo will retire as BDSI's President and Chief Executive Officer, roles which he has held since 2005.  Dr. Sirgo will remain as Vice Chairman of the Board of Directors where he will continue to provide leadership and guidance to BDSI.  Dr. Sirgo and the Board will work together during the coming months to determine his successor.

  • BioDelivery Sciences to Present Three Posters on BELBUCA® and BUNAVAIL® at PAINWeek 2017
    PR Newswire6 days ago

    BioDelivery Sciences to Present Three Posters on BELBUCA® and BUNAVAIL® at PAINWeek 2017

    RALEIGH, N.C. , Aug. 17, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) will present three posters reviewing the potential impacts of BELBUCA ® (buprenorphine) buccal film ...